Thursday, March 5, 2020

ChineseInvestors.com Inc. (CIIX) Launches Media Campaign Raising Awareness of CBD-Oil Benefits


  • CEO announces that company will sponsor infomercials touting benefits of CBD oil sold through CBD Biotech Co. subsidiary
  • CBD-oil awareness campaign consists of China AM radio infomercial, WeChat group infomercial and New York radio infomercial
  • CIIX planning to expand CBD product offerings in China
ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang announced during a MoneyTV interview that CIIX is launching a media campaign to raise awareness of the benefits of CBD oil (http://ibn.fm/PqQCy). The multimedia campaign consists of three infomercials: one aired on AM radio in China, one posted on WeChat and one aired on New York radio.

“A lot of people do not understand the benefits of CBD oil,” Wang noted during the broadcast interview. Sharing the benefits of CBD oil is a priority for the company because its China subsidiary, CBD Biotech Co., is expanding its CBD product offerings.

During his interview with MoneyTV host Donald Baillargeon, Wang said the purpose of the media campaign is to raise awareness – and ultimately sales – of CBD oil products offered by CBD Biotech.

“We will have an infomercial in an AM radio show in China for one month to start to create an awareness campaign to explain the benefits of CBD oil and the differences between full-spectrum CBD and CBD isolate,” Wang said. “We believe that CBD oil is very helpful to your health. We see CBD oil as a huge, huge market over the next three-six months.”

The educational infomercial by CIIX shared on a WeChat group site puts the company’s CBD-oil media-awareness campaign at the heart of Chinese social media. WeChat is a multipurpose messaging, social-media and payment app popular with consumers and used for everything from games, video calls, food ordering and news content. WeChat is China’s largest messaging app with a base of more than one billion people. The New York radio infomercial also raises the company’s profile in the United States and with its American audience of Chinese-speaking investors.

In addition to the campaign, CIIX’s website — ChineseInvestors.com — explains the health benefits of CBD oil and details where consumers can buy CBD oil through the company’s online store. Online consumers can also purchase hemp-derived CBD products such as soft gels, capsules and concentrates on the site. The site also educates consumers about CBD, the CBD market and the differences between full-spectrum CBD and CBD isolate.

During the interview, Wang also noted that the company plans on using social-media multiplatform techniques to market CBD products as it moves to boost online sales in China through CBD Biotech Co.

In earlier interviews, Wang noted that, through e-commerce and social-media platform promotion, he sees CBD Biotech reaching profit starting in the fourth quarter of 2020 fiscal year and throughout 2021 fiscal year.

Besides offering its audience of investors real-time market commentary, analysis and educational-related services, CIIX also provides consulting services to smaller private companies looking to go public, in addition to advertising, social media, and public relations consulting services. Based in San Gabriel, California, the company was created in 1999 and went public in 2011.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html